Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

EDARBYCLOR DIN 02397749

Status: Marketed
Holder: BAUSCH HEALTH, CANADA INC.
Molecule: AZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM)
Available to quote

Health Canada record

Active ingredient(s)AZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM) 40 MG; CHLORTHALIDONE 12.5 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCC09DA09 AZILSARTANT MEDOXIMIL AND DIURETICS
Original market date21-Mar-2013
Current status date13-Jul-2021
SourceHealth Canada DPD

Establishment licence of the holder

Bausch Health Companies Inc. — licence 101880, currently licensed, last inspection rating C (2026-06-01).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing AZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM)

DINProductCompanyFormStrengthStatus
02547015AURO-AZILSARTAN MEDOXOMILAURO PHARMA INCTabletAZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM) 40 MGMarketed
02547023AURO-AZILSARTAN MEDOXOMILAURO PHARMA INCTabletAZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM) 80 MGMarketed
02381389EDARBIBAUSCH HEALTH, CANADA INC.TabletAZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM) 40 MGMarketed
02381397EDARBIBAUSCH HEALTH, CANADA INC.TabletAZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM) 80 MGMarketed
02397765EDARBYCLORBAUSCH HEALTH, CANADA INC.TabletAZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM) 40 MG; CHLORTHALIDONE 25 MGMarketed
02397757EDARBYCLORBAUSCH HEALTH, CANADA INC.TabletAZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM) 80 MG; CHLORTHALIDONE 12.5 MGDormant

Notices of Compliance

NOCDateSubmissionReason
262492021-07-13New Drug Submission (NDS)Administrative: Change in Product Ownership Updates to the Product Labelling
180212016-04-22New Drug Submission (NDS)Administrative - Transfer of Drug Identification Number (DIN)
139232012-12-03New Drug Submission (NDS)
Request a quote for EDARBYCLOR

How to read a Canadian DIN record